Nevirapine News and Research

RSS
Maternal antiretroviral treatment eliminates HIV transmission to infants during breastfeeding

Maternal antiretroviral treatment eliminates HIV transmission to infants during breastfeeding

12 months of liquid formula HIV drugs protect breastfeeding babies against HIV infection

12 months of liquid formula HIV drugs protect breastfeeding babies against HIV infection

Study evaluates effectiveness of antiretroviral treatment in HIV-infected children

Study evaluates effectiveness of antiretroviral treatment in HIV-infected children

Three-drug regimen taken during pregnancy prevents mother-to-child HIV transmission

Three-drug regimen taken during pregnancy prevents mother-to-child HIV transmission

Janssen submits sNDA to FDA for simeprevir in combination with sofosbuvir for treatment of HCV genotype 1 infection

Janssen submits sNDA to FDA for simeprevir in combination with sofosbuvir for treatment of HCV genotype 1 infection

FDA approves OLYSIO (simeprevir) for treatment of chronic hepatitis C infection

FDA approves OLYSIO (simeprevir) for treatment of chronic hepatitis C infection

Discovery provides clues for potentially eliminating HIV infection in children

Discovery provides clues for potentially eliminating HIV infection in children

Study highlights long-term benefits of early antiretroviral therapy initiated in infants

Study highlights long-term benefits of early antiretroviral therapy initiated in infants

Indonesia issues order to override patents on 7 HIV, hepatitis drugs

Indonesia issues order to override patents on 7 HIV, hepatitis drugs

Combination regimens trump monotherapy in fight against HIV transmission

Combination regimens trump monotherapy in fight against HIV transmission

Less expensive ARV combination just as effective for women in developing countries as costlier ARVs, study shows

Less expensive ARV combination just as effective for women in developing countries as costlier ARVs, study shows

Breckenridge finalizes agreement with Huahai to market Nevirapine Tablets

Breckenridge finalizes agreement with Huahai to market Nevirapine Tablets

Daily ART safe and effective in preventing mother-to-child HIV transmission

Daily ART safe and effective in preventing mother-to-child HIV transmission

Enrollment complete in Boehringer Ingelheim's BI 201335 Phase III trial for HCV

Enrollment complete in Boehringer Ingelheim's BI 201335 Phase III trial for HCV

Gilead, Bristol-Myers Squibb to develop and commercialize fixed-dose combination for HIV

Gilead, Bristol-Myers Squibb to develop and commercialize fixed-dose combination for HIV

Matrix receives FDA's tentative approval for novel co-packaged version of HIV/AIDS therapy

Matrix receives FDA's tentative approval for novel co-packaged version of HIV/AIDS therapy

Study shows possibility of women living with AIDS to breastfeed with lower risk

Study shows possibility of women living with AIDS to breastfeed with lower risk

Boehringer Ingelheim receives FDA approval for Viramune XR to treat HIV-1 infection

Boehringer Ingelheim receives FDA approval for Viramune XR to treat HIV-1 infection

Boehringer Ingelheim's BI 201335 new data against HCV highlighted at EASL meeting

Boehringer Ingelheim's BI 201335 new data against HCV highlighted at EASL meeting

HIV prevention, treatment highlighted at Conference on Retroviruses and Opportunistic Infections

HIV prevention, treatment highlighted at Conference on Retroviruses and Opportunistic Infections